Publications
ORCID ID: https://orcid.org/0009-0001-6193-9586
​
Books edited
HR Ashbee, E Bignell.
Handbook of Pathogenic Yeasts. Springer, 2010.
---
HR Ashbee, MS Mathews.
Ananthanarayan and Paniker’s Textbook of Microbiology for Nurses. Universities Press, 2010.
​
General Mycology
HR Ashbee.
General approaches for direct detection and identification of fungi.
In: Manual of Clinical Microbiology, 12th edn. Ed: D Warnock. ASM Press. 2019. Vol 2, Chap 119, pp2035-2055.
---
MS Mathews, HR Ashbee.
Emerging Yeast Pathogens. In: Handbook of Pathogenic Yeasts. Eds: HR Ashbee, E Bignell. Springer, 2010. Chap 11, pp231-251
---
RJ Hay, HR Ashbee.
Mycology. In: Rook’s Textbook of Dermatology, 8th Edn. Eds: A Burns, S Breathnach, N Cox, C Griffiths. Blackwell Publishing, 2010. Chap 36, 36.1-36.93
---
RC Michael, JS Michael, HR Ashbee, MS Mathews.
Mycological profile of fungal sinusitis: An audit of specimens over a 7- year period in a tertiary care hospital in Tamil Nadu. Indian Journal of Pathology and Microbiology (2008) 51:493-496
---
HR Ashbee, EGV Evans, MA Viviani, B Dupont, E Chryssanthou, I Surmont, A Tomsikova, P Vachkov, B Ener, J Zala, K Tintelnot and the ECMM Working Group on Histoplasmosis.
Histoplasmosis in Europe: Report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Medical Mycology (2008) 46: 57-65
---
RC Barton, HR Ashbee, EGV Evans.
Specimen examination. In: Clinical Microbiology Procedures Handbook, 2nd Edn. Ed: K Hazen. ASM Press, 2004. Section 8, pp8.3.1-8.3.9
---
EGV Evans, HR Ashbee.
Tropical Mycoses: Hazards to Travellers’. In: Tropical Mycology, Vol 2. Eds: R Watling, JC Frankland, AM Ainsworth, S Isaac, CH Robinson. CAB International, 2002. Chap 10, pp 145-163
---
HR Ashbee, EGV Evans.
Fungal infections. Biological Sciences Review, (1998) 11: 27-29
​
Antifungals
HR Ashbee, RA Barnes, EM Johnson, MD Richardson, R Gorton, WW Hope. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. Journal of Antimicrobial Chemotherapy (2014) 69: 1162-1176
---
HR Ashbee, MH Gilleece.
Pharmacogenomics of Antifungal Agents. In: Handbook of Pharmacogenomics and Stratified Medicine. Ed: S Padmanabhan. Elsevier, 2014. Chap 38, pp879-900
---
HR Ashbee, MH Gilleece.
Has the era of individualised medicine arrived for the antifungals? A review of antifungal pharmacogenomics. Bone Marrow Transplantation (2012) 47:881-894
---
LD Liebowitz, HR Ashbee, EGV Evans, Y Chong, N Mallatova, M Zaidi, D Gibbs and the Global Antifungal Surveillance Group.
A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagnostic Microbiology and Infectious Disease (2001) 37:27-33
​
Malassezia
HR Ashbee, R Bond.
Host-Pathogen Interactions. In Malassezia and the skin. Eds: A Velegraki, P Mayser, T Boekhout. Springer 2010. Chap 5, pp139-173
---
HR Ashbee, A Scheynius. Malassezia.
In: Handbook of Pathogenic Yeasts. Eds: HR Ashbee, E Bignell. Springer, 2010. Chap 10, pp209-230
---
HR Ashbee.
Update on the genus Malassezia. Medical Mycology (2007) 45: 287-303
---
HR Ashbee.
Recent developments in the immunology and biology of Malassezia species. FEMS Immunology and Medical Microbiology (2006) 47:14-23
---
HR Ashbee, AK Leck, JWL Puntis, WJ Parson, EGV Evans.
Skin colonization by Malassezia in neonates and infants. Infection Control and Hospital Epidemiology (2002) 23: 212-216
---
HR Ashbee, EGV Evans.
Immunology of the diseases associated with Malassezia species. Clinical Microbiology Reviews (2002) 15:21-57
---
MR Saadatzadeh, HR Ashbee, WJ Cunliffe, E Ingham.
Cell mediated immunity to the mycelial phase of Malassezia spp in patients with pityriasis versicolor and controls. British Journal of Dermatology (2001) 144:77-84
---
MR Saadatzadeh, HR Ashbee, KT Holland, E Ingham.
Production of the mycelial phase of Malassezia in vitro. Medical Mycology (2001) 39:487-493
---
E Gueho, T Boekhout, HR Ashbee, J Guillot, A van Belkum, J Faergemann.
The role of Malassezia species in the ecology of human skin and as pathogens. Medical Mycology (1998) 36: Supp 1, 220-229
---
HU Kim, HR Ashbee.
Analysis of nucleic acids in Malassezia furfur serovars A, B and C. Annals of Dermatology (1997) 9:1-7
---
KJ Ahn, HR Ashbee.
Determination of minimum inhibitory concentrations of several azole antifungals for Malassezia furfur. Annals of Dermatology (1996) 8:187-194
---
HR Ashbee, E Ingham, KT Holland, WJ Cunliffe.
Cell mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Experimental Dermatology (1994) 3:106-112
---
HR Ashbee, A Fruin, KT Holland, WJ Cunliffe, E Ingham.
Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Experimental Dermatology (1994) 3:227-233
---
HR Ashbee, E Ingham, KT Holland, WJ Cunliffe.
The carriage of Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. British Journal of Dermatology (1993) 129:533-540
​
Candidosis and Dermatophytosis
N Hetticarachchi, HR Ashbee, JD Wilson.
Prevalence and management of non-albicans vaginal candidiasis. Sexually Transmitted Infections (2010) 86:99-100
---
S Harman, HR Ashbee, EGV Evans.
Testing of antifungal combinations against yeasts and dermatophytes. Journal of Dermatological Treatment (2004) 15:104-107
---
SS El-Din, MT Reynolds, HR Ashbee, RC Barton, EGV Evans.
An investigation into the pathogenesis of vulvo-vaginal candidosis. Sexually Transmitted Infection (2001) 77:179-183
---
PP Walker, C Brown, HR Ashbee, EGV Evans, MT Reynolds.
Vaginal yeasts in the era of “over-the-counter” antifungals. Sexually Transmitted Infections (2000) 76:437-438
---
HR Ashbee, EGV Evans.
Fungi and skin. Microbiology Today (2000) 27, 132-134
​
Case Report
S Gaur, A Rajgopal, R Ashbee.
A successfully treated case of peritonitis due to Fusarium dimerum. Journal of Infection (2010) 61: 86-88
Skin Microbiology
HR Ashbee, SR Muir, WJ Cunliffe, E Ingham.
IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris. British Journal of Dermatology (1997) 136:730-733